NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

BioInvent International AB (publ) (ST: BINV)

 
BINV Technical Analysis
4
As on 29th Oct 2025 BINV STOCK Price closed @ 31.10 and we RECOMMEND Sell for LONG-TERM with Stoploss of 36.55 & Strong Sell for SHORT-TERM with Stoploss of 35.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BINVSTOCK Price

Open 25.70 Change Price %
High 31.55 1 Day 3.80 13.92
Low 25.25 1 Week 4.10 15.19
Close 31.10 1 Month 0.20 0.65
Volume 419921 1 Year 1.60 5.42
52 Week High 50.80 | 52 Week Low 23.30
 
ST Sweden Most Active Stocks
ENERS 0.00 %
LIPI 0.22 -4.35%
ERIC-B 95.12 3.89%
WYLD 0.01 0.00%
LUNE 21.97 6.65%
POLY 0.04 0.00%
QUIA 0.00 %
CANTA 3.50 18.24%
EURA 0.01 0.00%
AMNI 0.01 %
 
ST Sweden Top Gainers Stocks
KOPY 0.10 150.00%
SPIFF 0.04 33.33%
ECC-B 0.58 18.37%
CANTA 3.50 18.24%
UNIBAP 7.48 17.98%
IRIS 0.20 17.65%
IRIS 0.20 17.65%
SOZAP 0.14 16.67%
BINV 31.10 13.92%
EGTX 6.31 12.68%
 
ST Sweden Top Losers Stocks
SECI 0.01 -50.00%
SECI 0.01 -50.00%
ZICC 0.25 -34.21%
AUR 0.82 -31.67%
AUR 0.82 -31.67%
ALLR 1.55 -26.54%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
GIAB 0.10 -23.08%
 
 
BINV
Daily Charts
BINV
Intraday Charts
Whats New @
Bazaartrend
BINV
Free Analysis
 
BINV Important Levels Intraday
RESISTANCE43.24
RESISTANCE39.35
RESISTANCE36.94
RESISTANCE34.53
SUPPORT27.67
SUPPORT25.26
SUPPORT22.85
SUPPORT18.96
 
BINV Forecast October 2025
4th UP Forecast57.98
3rd UP Forecast49.36
2nd UP Forecast44.03
1st UP Forecast38.7
1st DOWN Forecast23.5
2nd DOWN Forecast18.17
3rd DOWN Forecast12.84
4th DOWN Forecast4.22
 
BINV Weekly Forecast
4th UP Forecast41.60
3rd UP Forecast38.23
2nd UP Forecast36.15
1st UP Forecast34.07
1st DOWN Forecast28.13
2nd DOWN Forecast26.05
3rd DOWN Forecast23.97
4th DOWN Forecast20.60
 
BINV Forecast2025
4th UP Forecast85.25
3rd UP Forecast67.88
2nd UP Forecast57.15
1st UP Forecast46.41
1st DOWN Forecast15.79
2nd DOWN Forecast5.05
3rd DOWN Forecast-5.68
4th DOWN Forecast-23.05
 
 
BINV Other Details
Segment EQ
Market Capital 2163430656.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BINV Address
BINV
 
BINV Latest News
 
Your Comments and Response on BioInvent International AB (publ)
 
BINV Business Profile
BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, rest of Europe, the United States, Japan, and internationally. Its lead drug candidate is BI-1206, a monoclonal antibody targeting CD32b, which is in Phase I/IIa clinical trials in patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia. The company is also developing cancer-associated regulatory T cells which modulate the immune system; and BI-1808 and BI-1910, an anti-TNFR2 antibody for the treatment of solid tumors and cutaneous T-cell lymphoma (CTCL). It has a strategic collaboration with Pfizer Inc. for the development of antibodies against tumour-associated myeloid cells; partnership and collaboration with Transgene to co-develop multi-functional oncolytic viruses for treatment of solid tumors; and a collaboration agreement with SkylineDx to characterize the gene expression and immunological signatures in tumors of patients pre-and post-treatment with BI-1206. The Company was incorporated in 1996 and is headquartered in Lund, Sweden. Address: The Gamma Building, Lund, Sweden, 223 70
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service